Thermo Fisher Scientific announced the election of Karen S. Lynch to its board of directors, effective February 19, 2025, bringing the total number of board members to 12.

Ms. Lynch is a seasoned healthcare executive with over three decades of experience. She previously served as president and CEO of CVS Health, where she led over 300,000 employees and oversaw health care and pharmacy benefits for more than 120 million consumers. Prior to her leadership at CVS, she held executive positions at Aetna, Magellan Health Services, and Cigna. She began her career as a Certified Public Accountant at Ernst & Young and has served on the boards of CVS Health and U.S. Bancorp.

Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific, expressed enthusiasm about her appointment, emphasizing the value of her expertise as the company continues to grow.